Literature DB >> 31158344

Discrepancy between batches and impact on the sensitivity of point-of-care circulating cathodic antigen tests for Schistosoma mansoni infection.

Agostinho Gonçalves Viana1, Pedro Henrique Gazzinelli-Guimarães2, Vanessa Normandio de Castro3, Yvanna Louise de Oliveira Dos Santos4, Ana Cristina Loiola Ruas5, Fernando Schemelzer de M Bezerra6, Lilian Lacerda Bueno7, Silvio Santana Dolabella8, Stefan Michael Geiger9, Anna E Phillips10, Ricardo Toshio Fujiwara11.   

Abstract

The Kato-Katz (KK) technique is the mainstay mapping tool for the diagnosis of Schistosoma mansoni infection, despite showing poor sensitivity in cases of low-intensity infections. As an alternative, a rapid point-of-care circulating cathodic antigen diagnostic test (POC-CCA) has been commercially developed that involves a simple urine assay to detect S. mansoni, rather than a stool-based parasitological examination. Although POC-CCA has proven to be a more sensitive test than KK, it is not yet clear how to interpret discordant results between the two tests, particularly for situations in which the KK result is positive and the POC-CCA result is negative. Thus, the objective of this study was to evaluate the degree of diagnostic variability between different POC-CCA batches with respect to results obtained with KK. For this purpose, we collected urine and stool samples of school-aged children from areas of low and moderate endemicity in Brazil, and compared different POC-CCA batches results with those of KK-positive individuals. We found a statistically significant difference between the results obtained from various POC-CCA batches using the same urine samples, regardless of the degree of endemicity and the intensity of infection in positive KK samples. In addition, there was poor agreement between the KK and POC-CCA results in some batches of the rapid test, resulting in false negatives. These findings raise concerns around quality control checks of POC-CCA, especially in light of the high cost and increasing reliance on this new diagnostic method as control programs move towards a goal of elimination.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnosis; POC-CCA; Schistosoma mansoni; Schistosomiasis

Mesh:

Substances:

Year:  2019        PMID: 31158344     DOI: 10.1016/j.actatropica.2019.105049

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Evaluation, Validation, and Recognition of the Point-of-Care Circulating Cathodic Antigen, Urine-Based Assay for Mapping Schistosoma mansoni Infections.

Authors:  Daniel G Colley; Charles H King; Nupur Kittur; Reda M R Ramzy; William Evan Secor; Merlene Fredericks-James; Giuseppina Ortu; Michelle N Clements; Eugene Ruberanziza; Irenee Umulisa; Udo Wittmann; Carl H Campbell
Journal:  Am J Trop Med Hyg       Date:  2020-07       Impact factor: 2.345

2.  Case Report: Diagnosis and Assessment of Cure Approaches for Acute Schistosomiasis in Pre-School Children.

Authors:  Marta G Cavalcanti; Délia Celser Engel; Aline Fernandes de Araujo Cunha; José Mauro Peralta
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

3.  Evaluation of the Point-of-Care Circulating Cathodic Antigen Assay for Monitoring Mass Drug Administration in a Schistosoma mansoni Control Program in Western Kenya.

Authors:  Anne Straily; Emmy A Kavere; Dollycate Wanja; Ryan E Wiegand; Susan P Montgomery; Alex Mwaki; Alie Eleveld; W Evan Secor; Maurice R Odiere
Journal:  Am J Trop Med Hyg       Date:  2021-11-08       Impact factor: 3.707

4.  Reliability of point-of-care circulating cathodic antigen assay for diagnosing schistosomiasis mansoni in urine samples from an endemic area of Brazil after one year of storage at -20 degrees Celsius.

Authors:  Tereza Cristina Favre; Lilian Christina Nóbrega Holsback Beck; Fernando Schemelzer Moraes Bezerra; Carlos Graeff-Teixeira; Paulo Marcos Zech Coelho; Martin Johannes Enk; Naftale Katz; Ricardo Riccio Oliveira; Mitermayer Galvão Dos Reis; Otávio Sarmento Pieri
Journal:  Rev Soc Bras Med Trop       Date:  2022-02-25       Impact factor: 1.581

5.  Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?

Authors:  Jaspreet Toor; David Rollinson; Hugo C Turner; Anouk Gouvras; Charles H King; Graham F Medley; T Déirdre Hollingsworth; Roy M Anderson
Journal:  J Infect Dis       Date:  2020-06-11       Impact factor: 5.226

6.  Nationwide Remapping of Schistosoma mansoni Infection in Rwanda Using Circulating Cathodic Antigen Rapid Test: Taking Steps toward Elimination.

Authors:  Eugene Ruberanziza; Udo Wittmann; Aimable Mbituyumuremyi; Alphonse Mutabazi; Carl H Campbell; Daniel G Colley; Fiona M Fleming; Giuseppina Ortu; Govert J van Dam; Irenee Umulisa; Jamie Tallant; Michee Kabera; Muhammed Semakula; Paul L A M Corstjens; Tharcisse Munyaneza; Warren Lancaster; Jean Bosco Mbonigaba; Michelle N Clements
Journal:  Am J Trop Med Hyg       Date:  2020-05-14       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.